Pharma 777 Limited - Accounts to registrar (filleted) - small 23.2.5

REGISTERED NUMBER: 06764261 (England and Wales)

Unaudited Financial Statements

for the Year Ended 31 December 2022

for

PHARMA 777 LIMITED

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

4

Director:

R R Pietersen

Registered office:

3rd Floor

Marlborough House

298 Regents Park Road

Finchley

London

N3 2SZ

Registered number:

06764261 (England and Wales)

Accountants:

Haines Watts

Chartered Accountants

3rd Floor

Marlborough House

298 Regents Park Road

Finchley

London

N3 2SZ

Current assets

Stocks

-

18,611

Debtors

5

238,655

240,356

Cash at bank

4,354

664

243,009

259,631

Creditors

Amounts falling due within one year

6

534,434

551,055

Net current liabilities

(291,425

)

(291,424

)

Total assets less current liabilities

(291,425

)

(291,424

)

Creditors

Amounts falling due after more than one year

7

20

20

Net liabilities

(291,445

)

(291,444

)

Capital and reserves

Called up share capital

8

1

1

Retained earnings

(291,446

)

(291,445

)

Shareholders' funds

(291,445

)

(291,444

)

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2022.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2022 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Profit and Loss Account has not been delivered.

The financial statements were approved by the director and authorised for issue on 28 September 2023 and were signed by:

R R Pietersen - Director

1.	Statutory information

Pharma 777 Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).

2.	Accounting policies

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

The company meets its day to day working capital requirements with the use of a loan facility from the director, Mr Pietersen. Mr Pietersen has provided assurances that he will continue to provide financial support to the company and will not press for repayments of the amounts owed to him until such time as all other liabilities have been settled. The financial statements do not include any adjustments that would result from a withdrawal of the loan facility.

Key source of estimation, uncertainty and judgement

The preparation of financial statements in conformity with generally accepted accounting practice requires management to make estimates and judgement that affect the reported amounts of assets and liabilities as well as the disclosure of contingent assets and liabilities at the balance sheet date and the reported amounts of revenues and expenses during the reporting period.

There is estimation uncertainty in calculating depreciation. A full line by line review of fixed assets is carried out by management regularly. Whilst every attempt is made to ensure that the depreciation policy is as accurate as possible, there remains a risk that the policy does not match the useful life of the assets.

There is estimation uncertainty in calculating deferred tax. A full line by line review of deferred tax is carried out by management regularly. Whilst every attempt is made to ensure that the deferred tax is as accurate as possible, there remains a risk that the provisions do not match the actual tax liability when asset is disposed of.

There is estimation uncertainty in calculating bad debt provisions. A full line by line review of trade debtors is carried out at the end of each month. Whilst every attempt is made to ensure that the bad debt provisions are as accurate as possible, there remains a risk that the provisions do not match the level of debts which ultimately prove to be uncollectable.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Computer equipment

-

25% on cost

Stocks

Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Financial instruments

Financial assets and financial liabilities are recognised in the balance sheet when the company becomes a party to the contractual provisions of the instrument.

Trade and other debtors and creditors are classified as basic financial instruments and measured at initial recognition at transaction price. Debtors and creditors are subsequently measured at amortised cost using the effective interest rate method. A provision is established when there is objective evidence that the company will not be able to collect all amounts due.

Cash and cash equivalents are classified as basic financial instruments and comprise cash in hand and at bank and bank overdrafts.

Financial liabilities and equity instruments issued by the company are classified in accordance with the substance of the contractual arrangements entered into and the definitions of a financial liability and an equity instrument. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities. Equity instruments issued by the company are recorded at the proceeds received, net of direct issue costs.

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Profit and Loss Account, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Foreign currencies

Assets and liabilities in foreign currencies are translated into GBP sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into GBP sterling at the rate of exchange ruling at the date of transaction. Exchange differences are taken into account in arriving at the operating result.

3.	Employees and directors

The average number of employees during the year was 2 (2021 - 2 ) .

4.	Tangible fixed assets

Fixtures

and

Computer

fittings

equipment

Totals

£

£

£

Cost

At 1 January 2022

and 31 December 2022

1,283

1,908

3,191

Depreciation

At 1 January 2022

and 31 December 2022

1,283

1,908

3,191

Net book value

At 31 December 2022

-

-

-

At 31 December 2021

-

-

-

5.

Debtors: amounts falling due within one year

2022

2021

£

£

Trade debtors

103,684

105,558

Other debtors

134,798

134,798

VAT

173

-

238,655

240,356

6.

Creditors: amounts falling due within one year

2022

2021

£

£

Trade creditors

15,105

27,734

VAT

-

4

Other creditors

475,827

479,815

Accrued expenses

43,502

43,502

534,434

551,055

7.

Creditors: amounts falling due after more than one year

2022

2021

£

£

Other loans - 1-2 years

20

20

8.	Called up share capital

Allotted, issued and fully paid:

Number:

Class:

Nominal

2022

2021

value:

£

£

1

Ordinary

£1

1

1

9.	Related party disclosures

R R Pietersen is a beneficiary of the Pietersen Family Trust.

The balance due to the Pietersen Family Trust at the balance sheet date amounted to £475,827 (2021: £479,815) and is included within other creditors.

10.	Ultimate controlling party